Skip to content
1 Minute Read

CRIO Partners with Noir Research Collective to Drive Diversity and Efficiency in Clinical Trials

CRIO is excited to share our new partnership with Noir Research Collective (NRC), a minority-driven site network dedicated to empowering research sites with resources, training, and business support. This collaboration aligns with CRIO’s ongoing mission to provide innovative solutions that drive data quality, streamline clinical trial processes, and enhance patient safety.

“CRIO continually seeks opportunities to partner with industry colleagues striving to reach underrepresented populations. Noir Research Collective is taking an innovative approach to just that, and we’re excited to partner with them” said Raymond Nomizu, CRIO Founder and Co-CEO. “This collaboration highlights our shared commitment to increasing access, improving efficiency, and driving better outcomes across the clinical research landscape. Together, we’re building a more inclusive future for clinical trials.”

Image of Raymond Nomizu's quote about CRIO and the NRC's collaboration

NRC offers its members a robust suite of services, including diversity recruitment plans, regulatory oversight, centralized budgets, feasibility assessments, and managed CTMS solutions. Through this partnership, NRC and CRIO help to enable a streamlined approach to clinical trials and empower research sites to operate at peak efficiency.

Danielle Mitchell, Co-Founder of Noir Research Collective, on the partnership: “CRIO and Noir Research Collective are collaborating to transform the landscape of clinical research by enhancing diversity and fostering innovation. This partnership aims to dismantle existing barriers, creating a more inclusive and equitable environment that empowers underrepresented groups. By leveraging CRIO’s advanced eSource technology, which improves protocol compliance and increases diversity in clinical trials, and Noir Research Collective’s commitment to broadening participation, this alliance seeks to drive impactful changes in the industry. Together, they are committed to building a future where clinical research reflects the diverse populations it serves, ensuring better health.”

The NRC also provides unique resources, such as their Site Ownership Program and a member app designed to help members engage with NRC representatives, receive notifications about new studies, and interact with other members. The integration of CRIO’s solutions will further support NRC’s mission to streamline study acquisition and facilitate site interactions with industry leaders.

By combining CRIO’s cutting-edge eSource technology with NRC’s focus on diversity and site support, this partnership represents a significant step toward a more inclusive and efficient clinical research landscape. Together, CRIO and Noir Research Collective are committed to improving clinical trial processes and expanding access to life-changing treatments.

Learn more about Noir Research Collective.

CRIO favicon by Team CRIO
Share this post
You may also find interesting
Explore our Blog
CRIO Company News
4 Minute Read -

Introducing CRIO’s New AI-Powered Search Engine

We’re excited to announce a powerful new feature for our users – an AI-driven search engine designed to make finding information in CRIO’s Help Center faster, more accurate, and more intuitive than ever before. Let’s dive into how our new search functionality works, how you can access it, and how to use it effectively. How...

Rick Ward Announcement
CRIO Company News
1 Minute Read -

CRIO Welcomes Rick Ward as New Chief Commercial Officer

We are excited to announce the newest addition to the CRIO leadership team. Rick Ward joins us as our Chief Commercial Officer, bringing over 30 years of sales and marketing experience. Rick’s experience includes more than two decades as a proven leader in driving commercial growth strategies at dynamic eClinical solution providers including CluePoints, Greenphire...

CRIO x Sitero Case Study Graphic. Text inside of graphic: "CRIO & Sitero Partner to Drive Superior Enrollment, Speed, and Quality in Phase III Trial Using eSource"
CRIO Company News
2 Minute Read -

CRIO & Sitero Partner to Drive Superior Enrollment, Speed, and Quality in Phase III Trial Using eSource

In the world of clinical trials, speed and quality are paramount. Every day a trial is delayed translates to postponed access to potentially life-saving treatments. Furthermore, compromised data quality can jeopardize the entire study, leading to wasted resources and potentially harmful outcomes for patients. Research sites are at the heart of this process, acting as...

Get articles delivered to your inbox, every week